| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1517/14728222.11.11.1385 |
| P698 | PubMed publication ID | 18028005 |
| P2093 | author name string | Jay M Edelberg | |
| Victoria L T Ballard | |||
| P2860 | cites work | Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation | Q22004269 |
| Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand | Q24644662 | ||
| Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells | Q24672061 | ||
| The biology of VEGF and its receptors | Q27860704 | ||
| Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial | Q28196294 | ||
| Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI) | Q28216990 | ||
| Exploring vascular benefits of endothelium-derived nitric oxide | Q28288358 | ||
| Isolation of putative progenitor endothelial cells for angiogenesis | Q28302884 | ||
| Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium | Q28587604 | ||
| Tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system | Q28591291 | ||
| Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice | Q28593600 | ||
| Mechanisms of angiogenesis | Q29547485 | ||
| Angiogenesis in health and disease | Q29614541 | ||
| Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group | Q29615228 | ||
| Adult cardiac stem cells are multipotent and support myocardial regeneration | Q29620122 | ||
| Bone marrow-derived cells do not incorporate into the adult growing vasculature. | Q31031009 | ||
| PDGF mediates cardiac microvascular communication | Q37384601 | ||
| Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb | Q39425647 | ||
| Circulating endothelial progenitor cells, vascular function, and cardiovascular risk | Q39513285 | ||
| Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised cl | Q40525372 | ||
| Hematopoiesis and stem cell renewal in long-term bone marrow cultures containing catalase | Q41998583 | ||
| Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells | Q42498432 | ||
| Mobilization of endothelial progenitor cells in patients with acute myocardial infarction | Q43636896 | ||
| Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease | Q43664648 | ||
| Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation | Q44480707 | ||
| Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury | Q44693870 | ||
| Statins enhance migratory capacity by upregulation of the telomere repeat-binding factor TRF2 in endothelial progenitor cells. | Q45134152 | ||
| Defects in activation of nitric oxide synthases occur during delayed angiogenesis in aging | Q45275445 | ||
| Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferon | Q45749666 | ||
| Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease | Q45862672 | ||
| Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia | Q45886388 | ||
| Impaired progenitor cell activity in age-related endothelial dysfunction | Q46464362 | ||
| Year-by-year analysis of cardiovascular events in the Multiple Outcomes of Raloxifene Evaluation (MORE) trial | Q46479671 | ||
| Synergistic targeting with bone marrow-derived cells and PDGF improves diabetic vascular function | Q46844255 | ||
| Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms | Q47248012 | ||
| Implantation of BM cells transfected with phVEGF165 enhances functional improvement of the infarcted heart | Q47326578 | ||
| Growth factors reverse the impaired sprouting of microvessels from aged mice | Q47869131 | ||
| The mouse aorta model: influence of genetic background and aging on bFGF- and VEGF-induced angiogenic sprouting | Q47889556 | ||
| Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms | Q47945142 | ||
| Increase of circulating endothelial progenitor cells in patients with coronary artery disease after exercise-induced ischemia | Q48028832 | ||
| Cerebral angiogenesis and expression of angiogenic factors in aging rats after exercise | Q48654022 | ||
| Angiogenic murine endothelial progenitor cells are derived from a myeloid bone marrow fraction and can be identified by endothelial NO synthase expression. | Q50729092 | ||
| Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. | Q51010411 | ||
| Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. | Q51345347 | ||
| Stromal cell-derived factor and granulocyte-monocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy. | Q53663450 | ||
| PAR-1 activation on human late endothelial progenitor cells enhances angiogenesis in vitro with upregulation of the SDF-1/CXCR4 system. | Q54645645 | ||
| VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular endothelial precursor cells | Q57382170 | ||
| Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans | Q31113632 | ||
| Age-dependent impairment of angiogenesis | Q31936271 | ||
| Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial | Q33151955 | ||
| Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging | Q33193903 | ||
| Angiogenesis and vasculogenesis are impaired in the precocious-aging klotho mouse | Q33205670 | ||
| Bone-marrow-derived cell transfer after ST-elevation myocardial infarction: lessons from the BOOST trial | Q33234759 | ||
| The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals | Q33688733 | ||
| Gene therapy for myocardial angiogenesis | Q33699845 | ||
| Function of fibroblast growth factors and vascular endothelial growth factors and their receptors in angiogenesis | Q33933866 | ||
| The role of cerebral ischemia in Alzheimer's disease | Q33950413 | ||
| Cardioprotection with alcohol: role of both alcohol and polyphenolic antioxidants | Q33959761 | ||
| Circulating endothelial cells in vascular disorders: new insights into an old concept | Q34079981 | ||
| The role of FGF and VEGF in angioblast induction and migration during vascular development | Q34123470 | ||
| Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. | Q34228118 | ||
| Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial | Q34332467 | ||
| Therapeutic vasculogenesis using human cord blood-derived endothelial progenitors | Q34453467 | ||
| Aging and angiogenesis | Q35212910 | ||
| Angiogenic gene therapy with adenovirus 5 fibroblast growth factor-4 (Ad5FGF-4): a new option for the treatment of coronary artery disease | Q35582622 | ||
| Stem cell-derived angiogenic/vasculogenic cells: possible therapies for tissue repair and tissue engineering | Q35608881 | ||
| Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis | Q36111400 | ||
| Regulation of growth arrest in senescence: telomere damage is not the end of the story | Q36288403 | ||
| Myocardial aging--a stem cell problem | Q36291645 | ||
| Transplantation of umbilical cord blood-derived endothelial progenitor cells: a promising method of therapeutic revascularisation | Q36338824 | ||
| Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. | Q36369295 | ||
| Cellular memory and hematopoietic stem cell aging | Q36385580 | ||
| Senescent impairment in synergistic cytokine pathways that provide rapid cardioprotection in the rat heart. | Q36402343 | ||
| Oxidative damage and age-related functional declines | Q36417357 | ||
| Angiopoietins and angiopoietin-like proteins in angiogenesis | Q36489760 | ||
| Vascular endothelial growth factor A (VEGF-A) mRNA expression levels decrease after menopause in normal breast tissue but not in breast cancer lesions | Q36619626 | ||
| The discovery of endothelial progenitor cells. An historical review | Q36657139 | ||
| Vascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicine | Q36756406 | ||
| Generation of functional hemangioblasts from human embryonic stem cells. | Q37154210 | ||
| Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells | Q37376612 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | 1385-1399 | |
| P577 | publication date | 2007-11-01 | |
| P1433 | published in | Expert Opinion on Therapeutic Targets | Q5421214 |
| P1476 | title | Targets for regulating angiogenesis in the ageing endothelium | |
| P478 | volume | 11 |
| Q90614933 | A novel tissue culture model for evaluating the effect of aging on stem cell fate in adult microvascular networks |
| Q33582866 | Circulating endothelial progenitor cells: a new approach to anti-aging medicine? |
| Q33550596 | Comparison of endothelial progenitor cell function in type 2 diabetes with good and poor glycemic control |
| Q37589340 | Differential gene expression in Lin-/VEGF-R2+ bone marrow-derived endothelial progenitor cells isolated from diabetic mice |
| Q37316399 | Impact of endothelial microparticles on coagulation, inflammation, and angiogenesis in age-related vascular diseases |
| Q24310560 | S-endoglin expression is induced in senescent endothelial cells and contributes to vascular pathology |
| Q37132137 | Stem cells for cardiovascular repair - the challenges of the aging heart |
Search more.